ABSCIENCES (EPA:AB) | WebDisclosure

BRIEF

published on 06/09/2025 at 08:05, 11 months 12 days ago

EMA Approves Extended Shelf-Life for MASIVET® by AB Science

Veterinary Medicine AB Science EMA Approval MASIVET® Shelf-life Extension
BRIEF

published on 06/09/2025 at 08:05, 11 months 12 days ago

L'EMA approuve la prolongation de la durée de conservation de MASIVET® d'AB Science

Médecine Vétérinaire AB Science Approbation De L'EMA MASIVET® Prolongation De La Durée De Conservation
PRESS RELEASE

published on 06/09/2025 at 08:00, 11 months 12 days ago

AB Science announces EMA approval of Masivet shelf-life extension to 4 years
AB Science receives EMA approval for 4-year shelf-life extension of MASIVET(R) veterinary medicine, providing enhanced flexibility for patients and caregivers

Veterinary Medicine AB Science EMA Approval Shelf-life Extension MASIVET
PRESS RELEASE

published on 06/09/2025 at 08:00, 11 months 12 days ago

AB Science annonce l’approbation par l’EMA de la prolongation de la durée de conservation de Masivet à 4 ans
AB Science annonce l'approbation par l'EMA de la prolongation de la durée de conservation de Masivet à 4 ans, offrant une plus grande flexibilité et continuant à assurer les traitements actuels et futurs

Traitement AB Science EMA MASIVET Durée De Conservation
BRIEF

published on 05/23/2025 at 07:57, 11 months 29 days ago

AB Science renforce sa trésorerie avec une augmentation de capital

Euronext Paris Financement Augmentation De Capital Investisseurs AB Science
BRIEF

published on 05/23/2025 at 07:57, 11 months 29 days ago

AB Science strengthens its cash flow with a capital increase

Euronext Paris Investors Funding Capital Increase AB Science
PRESS RELEASE

published on 05/23/2025 at 07:52, 11 months 29 days ago

AB Science :
AB Science a réalisé avec succès une augmentation de capital de 1,8 million d’euros renforçant sa trésorerie et couvrant ses besoins de financement. Découvrez les détails dans ce communiqué de presse

Augmentation De Capital Trésorerie AB Science Masitinib AB8939
PRESS RELEASE

published on 05/23/2025 at 07:52, 11 months 29 days ago

AB Science announces the settlement delivery of its latest capital increase for €1.8 million
AB Science settles €1.8 million capital increase to strengthen cash position and cover financing needs; focuses on innovative drug development for various diseases

Healthcare Industry Financial News Capital Increase Drug Development AB Science
BRIEF

published on 05/20/2025 at 07:54, 1 year ago

AB Science Completes EUR 1.8 Million Private Placement

Private Placement Euronext Paris Share Warrants AB Science AB8939 Development
BRIEF

published on 05/20/2025 at 07:54, 1 year ago

AB Science finalise un placement privé de 1,8 million d'euros

Euronext Paris Placement Privé Bons De Souscription D'actions AB Science Développement AB8939

Published on 05/21/2026 at 15:00, 5 hours 48 minutes ago

Karbon-X Expands Global Energy Attribute Certificate Market Capabilities Amid Growing Renewable Procurement Demand
Published on 05/21/2026 at 14:30, 6 hours 18 minutes ago

Rio Grande Resources Advances District-Scale Gold-Silver Target Definition at its Winston Project Through Structural Mapping of Multiple Vein Corridor Systems
Published on 05/21/2026 at 14:00, 6 hours 48 minutes ago

Nextech3d.ai to Showcase AI Event Operating System and Krafty Labs Marketplace at Leading EMRG Media Event in New York
Published on 05/21/2026 at 14:00, 6 hours 48 minutes ago

Jade Leader Reviews Its Available Critical Minerals Assets
Published on 05/21/2026 at 14:00, 6 hours 48 minutes ago

Horizon Aircraft Advances Dual-Use Certification Path Through Cert Center Canada Partnership

View all ACCESSWIRE

Published on 05/21/2026 at 20:10, 37 minutes ago

Ernst Russ AG Divests MV 'EF Emira' and Raises Full-Year 2026 Guidance
Published on 05/21/2026 at 20:05, 42 minutes ago

EQS-Adhoc: Ernst Russ AG: Upward revision of the guidance for the financial year 2026
Published on 05/21/2026 at 20:00, 47 minutes ago

VINFAST INTRODUCES THE NEW-GENERATION VF 8, FEATURING COMPREHENSIVE ENHANCEMENTS
Published on 05/21/2026 at 18:26, 2 hours 21 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/21/2026 at 18:00, 2 hours 48 minutes ago

E-PANGO: Mise en place d’un financement obligataire d’un montant nominal maximum de 4 M€

View all EQS

Published on 05/21/2026 at 17:50, 2 hours 58 minutes ago

CDA - H1 results 2025 2026
Published on 05/21/2026 at 17:45, 3 hours 3 minutes ago

CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 05/21/2026 at 17:45, 3 hours 3 minutes ago

CEGEDIM: DECLARATION D’ACTIONS ET DE DROITS DE VOTE
Published on 05/21/2026 at 17:45, 3 hours 3 minutes ago

CDA - Résultats de 1er semestre 2025 2026
Published on 05/21/2026 at 16:35, 4 hours 12 minutes ago

260521 BENETEAU Déclaration du nombre d'actions et de droits de vote au 30-04-2026

View all LES ECHOS COMFI WIRE

News